New Blood: Former Novartis Exec Transitions to Rubius Therapeutics
New Red-Blood-Cell-Derived Therapies Are Poised to Launch Rubius into the Spotlight.
Improving Human Health: The Promise of Epigenetics
A New Perspective for Genomic Research from Prof. Shankar Balsubramanian
Translating Innovation into Therapies
Antimicrobial Resistance and Drug Commercialization Were Key Topics at the Recent ON Helix Conference in Cambridge, U.K.
Literature Review: Dielectrophoresis to the Fore
Old Methodology Resurrected to Allow Inexpensive Label-Free Separation of Cell Populations
- TTP LabTech
- Melbourn Science Park
- Royston, Herts , SG8 6EE
- UNITED KINGDOM
Having developed successful technologies for industries as diverse as telecommunications, printing and pharmaceuticals, The Technology Partnership plc (TTP) is Europe's leading independent centre for innovation.
TTP has its headquarters at its own 16-acre science park near Cambridge, UK and has the research, development and manufacturing facilities needed to deliver innovative products and services to companies worldwide.